Eli Lilly is making a significant move to fortify its global network for manufacturing parenteral products by acquiring a facility from Nexus Pharmaceuticals. This strategic step is set to greatly enhance Lilly's ability to supply its growing number of medications and underscores a commitment to
The intersection of social media and pharmaceutical regulation hit a flashpoint when Pfizer, a leading company in COVID-19 vaccine development, faced repercussions for a seemingly innocuous tweet. While social networks provide a powerful platform for sharing news and advancements, they also raise
